![]() |
VT and Symptomatic Bradycardia 2° Hyperkalemia - Printable Version +- BCSN Members Forum (https://forum.bcsimulation.ca) +-- Forum: Simulation Scenario Repository (https://forum.bcsimulation.ca/forumdisplay.php?fid=1) +--- Forum: Adult (https://forum.bcsimulation.ca/forumdisplay.php?fid=2) +---- Forum: Cardiology (https://forum.bcsimulation.ca/forumdisplay.php?fid=6) +---- Thread: VT and Symptomatic Bradycardia 2° Hyperkalemia (/showthread.php?tid=95) |
VT and Symptomatic Bradycardia 2° Hyperkalemia - ckchoung - 03-03-2020 VT and Symptomatic Bradycardia 2° Hyperkalemia
Created December 2019
Developed by:
Christina Choung
Developed for: Health Authority High Acuity Unit
Submitted by: ckchoung
Contact Email: simulation@fraserhealth.ca
Peer Reviewed: No
Case Summary: A 68 year old gentleman with a history of coronary artery disease (CAD), Diabetes Mellitus (DM) Type II, hypertension (HTN) and chronic kidney disease (CKD) requiring hemodialysis (HD) twice a week is being admitted for continuous renal replacement therapy (CRRT), bradycardia, and hypotension. Upon admission, he will quickly deteriorate to VT. After ROSC is achieved, he will return to a symptomatic bradycardia requiring transcutaneous pacing (TCP) or an increase in chrono- and iontropic & vasopressor support Target Learning Groups: Physicians, Nursing, Respiratory Therapy, Interprofessional Team Additional Target Learning Groups: Proposed Setting: High Acuity Unit Educational goals: • Identify and practice correct ACLS algorithms for patient presentation • Practice calling a Code Blue using the overhead paging system • Practice documentation during a Code Blue • Establish role clarity and distribute the workload accordingly • Communicate effectively using closed-loop communication, case and plan of care summaries, making clear requests, and fostering input from team members Additional Details: References: Scenario Links: Additional Tags: If you would like further information about this scenario please contact simulation@fraserhealth.ca or leave a comment below. |